相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Evolving concepts in HER2 evaluation in breast cancer: Heterogeneity, HER2-low carcinomas and beyond
Caterina Marchio et al.
SEMINARS IN CANCER BIOLOGY (2021)
Prognostic impact of HER2-low expression in hormone receptor positive early breast cancer
Raz Mutai et al.
BREAST (2021)
Clinical, pathological, and PAM50 gene expression features of HER2-low breast cancer
Francesco Schettini et al.
NPJ BREAST CANCER (2021)
The Exciting New Field of HER2-Low Breast Cancer Treatment
Daniel Eiger et al.
CANCERS (2021)
Ki67 as Proliferative Marker in Patients with Early Breast Cancer and Its Association with Clinicopathological Factors
Amelie de Gregorio et al.
ONCOLOGY (2021)
Efficacy, Safety, and Tolerability of Pertuzumab, Trastuzumab, and Docetaxel for Patients With Early or Locally Advanced ERBB2-Positive Breast Cancer in Asia The PEONY Phase 3 Randomized Clinical Trial
Zhimin Shao et al.
JAMA ONCOLOGY (2020)
Pertuzumab, trastuzumab, and docetaxel for HER2-positive metastatic breast cancer (CLEOPATRA): end-of-study results from a double-blind, randomised, placebo-controlled, phase 3 study
Sandra M. Swain et al.
LANCET ONCOLOGY (2020)
Trastuzumab emtansine with or without pertuzumab versus trastuzumab with taxane for human epidermal growth factor receptor 2-positive advanced breast cancer: Final results from MARIANNE
Edith A. Perez et al.
CANCER (2019)
Ki-67 index value and progesterone receptor status can predict prognosis and suitable treatment in node-negative breast cancer patients with estrogen receptor-positive and HER2-negative tumors
Nobuyuki Arima et al.
ONCOLOGY LETTERS (2019)
A Retrospective Analysis of Ki-67 Index and its Prognostic Significance in Over 800 Primary Breast Cancer Cases
Fabinshy Thangarajah et al.
ANTICANCER RESEARCH (2017)
Ki-67 as a prognostic marker according to breast cancer molecular subtype
Nahed A. Soliman et al.
CANCER BIOLOGY & MEDICINE (2016)
Prognostic value of different cut-off levels of Ki-67 in breast cancer: a systematic review and meta-analysis of 64,196 patients
Fausto Petrelli et al.
BREAST CANCER RESEARCH AND TREATMENT (2015)
Analysis of clinically relevant values of Ki-67 labeling index in Japanese breast cancer patients
Kentaro Tamaki et al.
BREAST CANCER (2014)
Ki-67 is a prognostic parameter in breast cancer patients: results of a large population-based cohort of a cancer registry
E. C. Inwald et al.
BREAST CANCER RESEARCH AND TREATMENT (2013)
Moderate Immunohistochemical Expression of HER-2 (2+) Without HER-2 Gene Amplification Is a Negative Prognostic Factor in Early Breast Cancer
Valentina Rossi et al.
ONCOLOGIST (2012)
Ki-67 as a prognostic marker according to breast cancer subtype and a predictor of recurrence time in primary breast cancer
Reiki Nishimura et al.
EXPERIMENTAL AND THERAPEUTIC MEDICINE (2010)
Prognostic factors in 1038 women with metastatic breast cancer
R. Largillier et al.
ANNALS OF ONCOLOGY (2008)
Hormone receptor status, tumor characteristics, and prognosis: a prospective cohort of breast cancer patients
Lisa K. Dunnwald et al.
BREAST CANCER RESEARCH (2007)
Estrogen-receptor status and outcomes of modern chemotherapy for patients with node-positive breast cancer
DA Berry et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2006)
分享论文
